Zdrowie i gospodarka · 01/09/2017

FDA Clears Ketoconazole Tablets for Sale

The US Food and Drug Administration (FDA) has ruled that NIZORAL (ketoconazole) 200mg tablets were not withdrawn from the market due to safety or efficacy concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) referencing the medication.